SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Monday reported a loss of $31.6 million in its fiscal first quarter.

The South San Francisco, California-based company said it had a loss of 53 cents per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 62 cents per share.

The maker of synthetic DNA for the biotechnology industry posted revenue of $88.7 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $86.9 million.

For the current quarter ending in March, Twist Bioscience said it expects revenue in the range of $91 million to $93 million.

The company expects full-year revenue in the range of $372 million to $379 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TWST at https://www.zacks.com/ap/TWST